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ABSTRACT
Syndecans are integral membrane proteoglycans which have important cellular 
functions. They are thought to function as co-receptors for various extracellular ligands 
like extracellular matrix molecules, cell-cell adhesion molecules, and growth fectors. It 
is shown that they modulate cell proliferation, cell adhesion, cell motility, and cell fate 
upon such interactions. Recent studies indicated that they also modulate signal 
transduction events by their core protein interactions. Most of these interactions are 
through their highly conserved cytoplasmic domains. They contain PDZ domain binding 
site at their carboxy terminal end, and identification of PDZ protein interactions of 
Syndecans may be important to explain their role in signaling. We aimed to identify a 
protein-protein interaction between Syndecan-1 cytoplasmic domain and PDZ domains 
of CASK and AF-6 proteins with yeast two-hybrid technique. We showed that there is a 
detectable interaction between CASK and Syndecan-1 through these domains. Our 
results indicated that CASK PDZ domain binds to Syndecan-1 cytoplasmic domain 
when expressed in yeast, and this interaction may have important functions in signaling 
events.
Ill
ÖZET
Sindekan proteinleri önemli hücresel faaliyetlerde görev alan hücre zan 
proteoglikanlarındandır. Sindekanların, hücre dışı matriks molekülleri, hücreler arası 
bağlantı molekülleri, ve bazı büyüme hormonları gibi değişik hücre dışı ligandları için 
yardımcı reseptör olarak görev aldıkları düşünülmektedir. Önceden bu tip fonksiyonları 
sayesinde, hücre çoğalmasında, hücreler arası bağlantılarda, hücre haraketlerinde, ve 
hücre kaderinin belirlenmesinde ayarlayıcı rolleri gösterilmiştir. Yakın zamandaki 
çalışmalarda ise bu moleküllerin hücre içindeki protein zinciri bölümlerinin görev aldığı 
etkileşmeler sayesinde sinyal iletimi fonksiyonlarını ayarladıklan gösterilmiştir. Bu 
etkileşmelerin büyük bir kısmı bu moleküllerin büyük oranda korunmuş olan 
sitoplasmik bölgeleri yardımıyla gerçekleşmektedir. Sindekanların karboksil uçlarında 
sinyal iletimi olaylarındaki rollerirli açıklamada çok önemli olabilecek PDZ bölgesi 
bağlanma alanları bulunmaktadır. Biz, mayada melezleme tekniği ile sindekanların 
sitoplasmik bölgelerinin görev aldığı yeni protein etkileşmelerini ortaya çıkarmayı 
amaçladık. Bunun için CASK proteini ve AF-proteininin PDZ bölgeleri ile sindekanların 
sitoplasmik bölgeleri arasındaki etkileşmeleri mayada melezleme tekniği ile denedik. 
Çalışmalanmızm sonunda CASK proteini ile sindekan-I proteini arasında bir etkileşme 
olduğunu gösterdik. Sonuçlarımız gösterdi ki CASK proteini PDZ bölgesi sayesinde 
sindekan-1 proteininin sitoplasmik bölgesine, maya hücresi içerisinde eksprese 
edildikleri zaman bağlanabilmektedir. Ve bu etkileşmenin sinyal iletimi olaylarında 
önemli fonksiyonları olması muhtemeldir.
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1- INTRODUCTION
1.1-SYNDECANS
Syndecans are members of cell sürfece heparan sulphate proteoglycans (HSPG) 
consisting of a single membrane spanning domain, a short cytoplasmic domain, and a 
highly variable extracellular domain. Heparan sulphate chains attachment sites are 
localized on the extracellular domain o f Syndecans. These attachment sites are highly 
variable among the four members of the Syndecan femily whereas their locations and 
numbers are conserved through evolution for each single member of the family.
1.1.1- Syndecan core protein
Syndecans are long unbranched proteoglycans consist of a core protein, to which 
long unbranched carbohydrate polymers namely glycosaminoglycans are covalently 
attached (Saunders et al. 1989, Mali et al. 1990). According to a common nomenclature 
Syndecans are designated numerically (from 1 to 4) with respect to their cloning order 
(Carey etal. 1992).
Syndecans are also cloned from some basic organisms such as Drosophila 
melanogaster, and Caenorhabditis elegans (Spring et al. 1994). In mice and humans, 
each of the four syndecan genes is located on a different chromosome. Genes coding for 
Syndecans I, 3 and 4 have been cloned (Carey et al. 1997). They show a strikingly
similar exon-intron organization, which supports the idea that the Syndecans arose by 
gene duplication from a single ancestral gene (Carey 1997). A schematic representation 
of all Syndecans is shown in Figure 1.1.
1.1.2- Functions of Syndecans
Large number of ligands have been identified that bind to Syndecans at their 
extracellular domains. These encompass an amazing variety of molecules, including 
growth factors, extracellular-matrix proteins, cell-cell adhesion receptors, enzymes and 
other proteins (Schlessinger et al. 1995). In most cases the specificity of binding of these 
ligands to Syndecans appears to be relative and not absolute. For example, although 
bFGF binds to specific sugar sequences within heparan sulphate chains, every syndecan 
that has been examined appears to contain these sequences and binds bFGF (Lopez 
Casillas et al. 1993). On the other hand, bFGF has its own receptor bFGFR. These 
features appear to rule out the notion that Syndecans function as ligand-activated 
signaling receptors in the usual sense.
According to these notions Syndecans have been thought to function as co­
receptors that bring extracellular ligands into close proximities to their specific 
receptors. For a long time these membrane proteins are considered to be fine tuners of 
ligand-receptors interactions, and they are conceived to be modulators of cell adhesion, 
cell migration, and cell differentiation.
(a)
J i
^ Svndecan-1
^  Syndecaii-3
^  Svndecan-2
□ZD Syiidecan-4
I . .1 I Drosophila
(b )
I C. elegans Syndecan
Syn-3 KSILERKE VLVAVIVGG WGALFAAFLVTL LIY EMKKKDEGSYTLEEPKQASVT YQ KP DKQEEFYA 
Syn-l QGLLDRKE VLGGVIAGG LVGLIFAVCLVAF MLY EMKKKDEGSYSLEEPKQANGG AYQ KP TKQEEFYA 
Syn-4 DNLFKRTE VLAAVIAGG VIGFLFAIFLILL LVY EMRKKDEGSYDLGERKPSS AAYQ K APTK EFYA 
Syn-2 SNIFERTE VLAALIVGG WGILFAVFLILL LVY RMKKKDEGSYDLG KKPI Y KK APTN EFYA 
Dr. SSFFSQPG ILAAVI GGAWGLLCA IL^ /"/MFIVY RMRKKDEGSYALDEPKRSPANNSY AKNA NNREFYA 
C. e FHETLANG FYAA lAGGVLVAVITA ILLVLFWF RIRKKD-EGSYALDEPKQARPYASYGYTK ASTK EFYA
Figure l . l :  Structure of Syndean core protein
(a) Diagram illustrating the structures of the four vertebrate and two invertebrate 
Syndecans. The black boxes represent the transmembrane domains. Vertical lines above 
the boxes indicate positions of attachment of heparan sulphate chains, (b) Amino acid 
sequences of syndecan transmembrane and cytoplasmic domains.
The cytoplasmic domains are short but highly conserved. The sequence of the 
13-amino-acid segment immediately following the transmembrane domain is essentially 
identical in all Syndecans, including the invertebrate forms (Cl region). All syndecan 
core proteins also contain an identical tetrapeptide sequence at their C-terminal ends (C2 
region). The function of these portions of the cytoplasmic domain is unknown. 
Interrupting these highly conserved segments is a variable region that shows 
considerably less sequence similarity among syndecan types (V region). Interestingly, 
however, the variable-region sequences are highly conserved for specific Syndecans 
types in different species. The sequence of syndecan-1 in this region is identical in 
human, mouse, rat and hamster; the corresponding region in syndecan-2 is identical in 
human, rat and Xenopus. Thus, once the four vertebrate syndecan genes diverged during 
evolution, there was strong selective pressure to maintain their particular cytoplasmic 
domain primary structures. This, plus the structural diversity of the ectodomains, 
suggests that different Syndecans have evolved to carry out similar, but non-identical, 
functions.
The conserved characteristic of cytoplasmic domain of syndecan proteins 
indicate that these domains have important cellular functions and may bind to different 
cytoplasmic proteins. These possible interactions may be important for the determination 
of cell fate. Most probably Syndecan proteins regulate cell-matrix and cell-cell 
interactions outside the cell membrane and they also modulate cell signaling by 
signaling receptors through protein-protein interactions inside the cell via their highly 
conserved cytoplasmic domains.
1.1.3- Cytoplasmic domains of Syndecans
N-syndecan (Syndecan-3) was previously isolated as a cell sur&ce receptor for 
heparin-binding growth-associated molecule (HB-GAM) and suggested to mediate the 
neurite growth-promoting signal from cell matrix-bound HB-GAM to the cytoskeleton 
of neurites. However, it was unclear whether N-syndecan would possess independent 
signaling capacity in neurite growth or in related cell differentiation phenomena. Later it 
was reported that Syndecan-3 binds a protein complex containing Src family tyrosine 
kinases and their substrates and that Syndecan-3 acts as a neurite outgrowth receptor via 
the Src kinase-cortactin pathway (Kinnunen et al. 1998).
In 1995 it was sho\vn that S)mdecan-4 but not other Syndecans can be 
phosphorylated by Protein kinase C (PKC) which is an important protein in cell 
signaling events (Prasthofer et al. 1995, Baciu et al. 1995). It was shown that 
Syndecan-4 can be phosphorylated by PKC and is possibly a physiological substrate for 
PKC in cells. The core protein of S3mdecan-4 can directly bind the catal)4ic domain of 
PKCalpha and potentiate its activation by phospholipid mediators. It can also directly 
activate PKCalpha in the absence of other mediators. This activity resides in the 
sequence LGKKPIYKK in the center of the short cytoplasmic domain, and other 
Syndecans lack this sequence and PKC regulatory properties. Syndecan-4 is a focal 
adhesion component, and this interaction may both localize PKC and amplify its activity 
at sites o f forming adhesions (Oh et al. 1997). This was the first report suggesting direct 
transmembrane signaling through cell surface proteoglycans.
Another novel cellular protein was identified that interacts with the cytoplasmic 
domain of syndecan-4 but not with those of the other three syndecan family members. 
The interaction involves both the membrane proximal and variable central regions ofthe
1.1.4- Core protein interactions ofSyndecans
cytoplasmic domain. The protein is named as syndesmos. Syndesmos is ubiquitously 
expressed and can be myristylated. Consistent with its myristylation and syndecan-4 
association, syndesmos colocalizes with syndecan-4 in the ventral plasma membranes of 
cells plated on fibronectin (Baciu et al. 2000). When overexpressed in NIH 3T3 cells, 
syndesmos enhances cell spreading, actin stress fiber and focal contact formation in a 
serum-independent manner.
A third protein which was identified by yeast two-hybrid screening that binds to 
the cytoplasmic domains of the S5mdecans, is syntenin (Grootjans et al. 1997). It 
contains a tandem repeat o f PDZ domains that reacts with the FYA C-terminal amino 
acid sequence of the Syndecans. Cells that overexpress eGFP-syntenin show numerous 
cell sürfece extensions, suggesting effects of syntenin on cytoskeleton-membrane 
organization. It may be proposed that syntenin may function as an adaptor that couples 
Syndecans to cytoskeletal proteins or cytosolic downstream signal-effectors. This study 
was the first report suggesting PDZ proteins as interaction counterparts of Syndecan 
proteins.
CASK, the rat homolog of a gene (LIN-2) required for vulval differentiation in 
Caenorhabditis elegans, is expressed in mammalian brain, but its function in neurons is 
unknown (Hata et al. 1996). It is another member of PDZ protein family. Again by yeast 
two-hybrid screening, a specific interaction was identified between the PDZ domain of 
CASK and the COOH terminal tail of syndecan-2, a cell surface heparan sulphate 
proteoglycan (HSPG). The interaction was confirmed by coimmunoprecipitation from 
heterologous cells (Hsueh et al. 1998). In brain, syndecan-2 localizes specifically at 
synaptic junctions where it shows overlapping distribution with CASK, consistent with 
an interaction between these proteins in synapses. Cell surface HSPGs can bind to
extracellular matrix proteins, and are required for the action of various heparin-binding 
polypeptide growth/dififerentiation factors. The synaptic localization of CASK and 
syndecan suggests a potential role for these proteins in adhesion and signaling at 
neuronal synapses (Cohen etal. 1998).
All these interactions are indications of important cellular functions of Syndecan 
proteins other than their co-receptor functions. Some of the possible functions of such 
interactions may be association of focal adhesion complexes at cell to cell junctions, 
localizing membrane proteins or signaling molecules at specific membrane loci by 
communication with cytoskeletal proteins, or regulation of special cellular complexes. 
Some possible signaling pathways are Wnt-frizzled pathway, and CASK-reelin pathway 
which are summarized in the proceeding parts of this thesis.
Core protein interactions of Syndecans cytoplasmic domain are shown as a 
scheme in the Figure 1.2.
C l C2
Syndesmos-Syndecan-4 Cask-Syndecan-2 
Syntenin-Syndecan-1,2,3,4 
Src kinase-cortactin complex-Syndecan-3
Figure 1.2: Core protein interactions of Syndecans
Proteins interacting with cytoplasmic domain of Syndecans and their interaction sites are 
shown.
Wnt proteins are large family of cystein rich glycoproteins that ftinction as 
ligands controlling development in various organisms ranging from nematode worms to 
mammals. At the cellular level Wnt regulates cell proliferation, cell morphology, cell 
motility, and cell fete. Wnt proteins serve as short range chemical messengers, paracrine 
agents. Wnt proteins are associated with cell sürfece and extracellular matrix, such that 
their effects tend to be spatially localized. The first mammalian Wnt gene, originally 
termed Int-1 was identified at a site of murine mammary tumor virus (MMTV) 
integration in mammary tumors (Burrus et al. 1995). The Int-1 gene exhibited homology 
to wingless [wg], a Drosophila segment polarity gene, and subsequently the name Wnt 
was chosen for members of this femily. At least sixteen mammalian Wnt genes have 
been identified so far. Wnt proteins elicit a variety of cellular responses, including 
proliferation, differentiation, and morphogenesis, and control of developmental 
decisions such as axis formation in Xenopus embryos. Indeed, Wnts are now recognized 
as one of the major classes of signaling proteins that regulate development and cell fate 
in multicellular organisms (Peifer 1996).
1.2- WNT-FRIZZLED PATHWAY
1.2.1- Wnt signaling
The action of Wnts on target cells is mediated by binding to the frizzled (Fz) 
group of transmembrane receptors, of which there are at least eight members in 
mammals. Structurally, Frizzled receptors have an extracellular Wnt-binding domain, 
seven-transmembrane-spanning sequences and an intracellular C-terminal tail (Bhanot et 
al. 1996). They form part of the seven-transmembrane-spanning (7TMS) superfamily of
receptors. The regulation of Wnt binding to Frizzled receptors is a key restriction point 
in Wnt signaling. The immediate downstream component of the signal transduction 
pathway is disheveled (Dsh), an intracellular protein that may directly interact with Fz 
receptors. Members of the Dishevelled family encode cytoplasmic proteins with no 
known enzymatic functions (Tsang et al. 1996). Sequence comparisons identified three 
regions of homology: an N-terminal Dsh homology domain, a central region containing 
a basic and a PDZ domain, and a DEP domain upstream of the non-conserved C- 
terminal sequence. The target of Dsh is glycogen synthase kinase-3 (GSK-3), which is 
homologous to the Drosophila protein encoded by zeste-white3. GSK-3 is believed to be 
constitutively active and functions to inhibit the Wnt pathway in the absence of Wnt 
signals. GSK-3 phosphorylâtes p-catenin, which enhances p-catenin turnover by a 
ubiquitin-mediated degradation pathway. P-Catenin is a member of a multigene family 
of proteins characterized by the presence o f 'Arm' amino acid repeats that mediate a 
range of protein-protein interactions. Genetic analysis of the Drosophila homologue 
Armadillo (Arm), showed that it functions downstream of GSK-3/zw3. Considerable 
evidence suggests that the Wnt inhibition of GSK-3 activity prevents the turnover of P- 
catenin, leading to its accumulation. In response to Wnt signals, GSK-3 activity is 
inhibited, leading to stabilization of the P-catenin protein. One of the targets o f P-catenin 
is the transcription fector TCF, an HMG-box DNA-binding protein. Multiple TCF 
family members exist in mammals, including TCF-1, LEF-1, TCF-3, and TCF-4. P- 
Catenin forms a complex with TCF, converting it from a transcriptional repressor to an 
activator and thereby stimulating the expression of target genes (Behrens et al. 1996). 
Although the genes in mammalian cells that are activated by TCFs in response to Wnt
signaling are not well characterized, the c-myc proto-oncogene is one target that may 
mediate proliferative responses to Wnt signals (He et al. 1998). In several versions of 
this model, the APC (adenomatous polyposis coli) gene product has been proposed to 
function as a signaling intermediate between GSK-3 and ß-catenin. In this context, the 
finding that APC can bind both ß-catenin and GSK-3 suggested that APC may function 
as a signaling scaffold (Cadigan & Nusse 1997, Siegfried et al. 1994). A schematic 
representation of Wnt signaling is shown in Figure 1.3.
1.2.2- Ligand binding
The Wnt-binding domain' found at the N-terminus of Frizzled femily members 
was recently identified in genes of the Frzb family and in a splicing variant of collagen 
XVIH. The complexity of receptor-ligand specificity may be further increased by co­
receptors such as proteoglycans and other putative 'Wnt receptors'. Proteoglycans consist 
of proteins linked to chains of disaccharide repeats called glycosaminoglycans. 
Proteoglycans are highly charged and are found predominantly at the cell surface, where 
they function as low-affinity cell-surface receptors for a variety of ligands, including 
TGF-ß and FGF. Cell-culture studies showed that many Wnt family members bind 
glycosaminoglycans (Reichsman et al. 1996) and that cell-surface glycosaminoglycans 
are required for Wg stabilization of Arm in Drosophila Cl-8 cells. Cell-surface 
proteoglycans may increase the local concentration of Wnts, leading to increased avidity 
and/or receptor clustering, as has been proposed in models for FGF-glycosaminoglycan 
interactions. Thus the loss of heparin-like glycosaminoglycans may allow Wnt proteins 
to abnormally diffuse and reach a concentration at which they are no longer effective.
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Wnt
Frizzled Frizzled
Figure 1.3: Wnt signaling
Following binding of the Wnt ligand to the Frz receptor, Dsh is recruited to the cell 
membrane, where it signals to inhibit the kinase activity of GSK-3. As GSK-3 normally 
promotes the instability o f soluble p-catenin, Wnt signaling results in an increase of 
P-catenin levels. Soluble P-catenin then interacts with TCF-DNA-binding factors, 
forming a transcriptionally active complex. In several versions of this model, the APC 
(adenomatous polyposis coli) gene product has been proposed to function as a signaling 
intermediate between GSK-3 and p-catenin (Dale T. C. Biochem J. 1998).
11
Alternatively, the ability of Wnt-Frizzled complexes to form or transduce their signals 
may be directly regulated by glycosaminoglycan interactions.
1.2.3- p-catenin vs. E-cadherin
P-Catenin encodes a 90 IcDa protein with several structural domains. The N- 
terminus contains the XGSK-3 phosphorylation sites. The central domain of the protein 
contains 13 imperfect 'Arm' repeats that fold to make a superhelix containing a 
positively charged groove that is hypothesized to interact with acidic regions of APC, 
TCF transcription factors and cadherin cell adhesion molecules (Huber et al. 1997).
Cadherins are Ca^^-dependent adhesion molecules that mediate cell-cell 
interactions at adhesive junctions. The intracellular domain of cadherins interact with the 
cytoplasmic adaptor proteins p-catenin or plakoglobin. While complexed to cadherins, 
P-catenin is also able to interact with a-catenin, a cytoplasmic protein with similarity to 
vinculin, which links actin filaments to the adherens junctions.
Levels o f cadherin expression affected free p-catenin pools and signaling, in 
Xenopus embryos, ES cells and Drosophila embryos. However, as E-cadherin-deficient 
L-cells were able to respond to Wnt-1 by stabilizing P-catenin, it is unlikely that the 
reductions in E-cadherin expression were sufficient or were required for Wnt signaling. 
Cell adhesion may be a downstream target of Wnt signaling as the adhesive functions of 
cadherins are regulated by interactions with P-catenin.
E-cadherin and lymphocyte-enhancer factor-1 (LEF-1) form mutually exclusive 
complexes with beta-catenin; the association of beta-eaten in with LEF-1 compete by the 
E-cadherin cytoplasmic domain. Similarly, LEF-1 and adenomatous polyposis coli
12
(APC) form separate, mutually exclusive complexes with beta-catenin. The potent 
ability of E-cadherin to recruit P-catenin to the cell membrane and prevent its nuclear 
localization and transactivation is demonstrated using SW480 colon carcinoma cells 
(Orsulic et al. 1999).
1.2.4- Wnt signaling vs. Syndecan-1
Syndecans bind to various different ligands including oncogenic proteins. But 
there were no direct evidence that Syndecans are involved in tumorigenesis. In a recent 
publication it was reported that they may have role in mammary tumor formation caused 
by ectopic Wnt-1 proto-oncogene. In this study, S)mdecan-1-deficient mouse and 
transgenic mouse that express Wntl in mammary gland are crossed. Ectopic Wnt-1 
expression is known to induce generalized mammary hyperplasia, followed by the 
development of solitary tumors (Ramakrishna et al. 1993). It is shown that in Sdcl-/- 
mice, Wnt-1-induced hyperplasia in virgin mammary gland was reduced by 70%, 
indicating that the Wnt-1 signaling pathway was inhibited. These results provide both 
genetic and biochemical evidence that syndecan-1 can modulate Wnt signaling, and is 
critical for Wnt-1-induced tumorigenesis of the mouse mammary gland (Alexander et al. 
2000).
CASK is identified as a neurexin, a neuronal cell surface protein binding 
counterpart in synaptic junctions of neurons (Hata et al. 1996). It shows a great 
homology to Drosophila PSD95 protein. Later a C. elegans homolog of CASK LIN-2 is 
identified which co-localizes with EOF receptors in cell membranes (Kaech et al. 1998). 
It belongs to Membrane Associated Guanylate Kinase (MAGUK) protein family. 
Members of this protein family all share some characteristics like being composed of 
multiple protein domain such that C terminal calcium/calmodulin binding domain,SH3 
domains and guanylate kinase domains. Guanylate kinase domain indicates that these 
proteins may bind to ATP through these regions and display kinase activities. Yet, no 
significant kinase activity could be shown to guanylate kinase domain of CASK.
MAGUK proteins are possibly involved in localization of multi protein 
complexes to cell sürfece proteins. These protein complexes may be involved in signal 
transduction events and are probably regulated by these scaffold proteins.
CASK is a membrane-associated protein that contains domains found in Ca^^ 
activated protein kinases and in proteins specific for intercellular junctions, suggesting 
that it may be a signaling molecule operating at the plasma membrane, possibly in 
conjunction with neurexins.
1.3.1- CASK and Syndecans
Another important domain of CASK is its PDZ like domain showing a similarity 
with drosophila PSD95 protein. This domain is also thought to be involved in protein- 
protein interactions of CASK. Later, CASK was reported to interact directly with
1.3- CASK-TBR-1 PATHWAY
14
Syndecan-2 protein via its cytoplasmic domain through this PDZ domain. It is 
hypothesized that PDZ domain of CASK may interact with all other Syndecan proteins 
via their carboxy terminal EFYA sequence. In brain, Syndecan-2 localizes specifically at 
synaptic junctions where it shows overlapping distribution with CASK, consistent with 
an interaction between these proteins in synapses.
It is logical to think that other members of Syndecan family of proteins are also 
interacting with CASK through the same domain. Yet no such study is reported 
indicating that CASK is interacting with a syndecan protein other than Syndecan-2. Cell 
surface HSPGs can bind to extracellular matrix proteins, and are required for the action 
of various heparin-binding polypeptide growth/dififerentiation factors. The s)maptic 
localization of CASK and sjmdecan suggests a potential role for these proteins in 
adhesion and signaling at neuronal synapses.
1.3.2- CASK in nucleus
A recent study reported that CASK interacts with a T-box protein (Tbr-1) which 
is a transcription factor. Tbr-1 binds DNA at a specific sequence (T-box) and activating 
the transcription of a protein named reelin (Hsueh et al. 2000). The interaction is through 
c a s k ’s mysterious guanylate kinase domain. This was the first function attributed to 
guanylate kinase domain of MAGUK proteins. However the interaction was specific to 
CASK alone and other MAGUK proteins did not show any interaction with Tbr-1 
protein.
The paradoxical finding of interaction o f a membrane associated MAGUK 
protein CASK, interacting with a transcription factor which normally resides in nucleus 
is solved when it is demonstrated that CASK localizes to nucleus in Tbr-1 over
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expressing cells. It was also shown that CASK activates the transcriptional activating 
function of Tbr-I protein through this interaction.
Tbr-I is a T-box transcription factor involved in forebrain development. CASK 
enters the nucleus and binds to a specific DNA sequence (the T-element) in a complex 
with Tbr-I. CASK acts as a coactivator of Tbr-I to induce transcription of T-element 
containing genes, including reelin, a gene that is essential for cerebrocortical 
development. This findings show that a MAGUK which is usually associated with cell 
junctions has a transcription regulation function.
Another important finding is regulation of this pathway by syndecan expression. 
Syndecan-3 over expression diminished the translocation of CASK to nucleus. This type 
of regulation can be observed in Wnt pathway where P-catenin translocation to nucleus 
is regulated by E-cadherin expression. Probably in CASK pathway Syndecans have 
similar functions to E-cadherin functions in Wnt pathway. S)mdecans are known to have 
important functions in developmental processes. This phenomenon may be a good 
example how these membrane glycoproteins are involved in developmental events.
CASK pathway resembles Wnt pathway in many ways indicating that both may 
have similar components and are regulated by similar mechanisms (Bredt 2000). A 
comparative diagram of both pathway is presented in Figure 1.4.
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Figure 1.4: Wnt pathway and CASK pathway
Wnt pathway is shown as a diagram in the left picture. The CASK pathway is shown in 
the right picture. The involvement of P-catenin in the pathway resembles the 
involvement of CASK in the other pathway. The other components of the CASK 
pathway are not characterized yet, but may have similar characteristics to Wnt pathway.
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Many cytosolic signaling proteins and cytoskeletal proteins are composed of 
modular units o f small protein-protein interaction domains like SH2 domains, SH3 
domains or PDZ domains. As the name implies, PDZ domain have high homology with 
the drosophila PSD95 proteins, disc-large gene encoded Dig protein, and ZO-1 protein. 
The first mammalian homolog identified was p55 protein which show a silent G/T 
polymorphism. PDZ domain containing proteins bind directly to the carboxy terminal 
residues of transmambrane proteins (RufFet al. 1996). For example PSD95 and Dig bind 
to similar carboxy terminal sequences on Shaker type K ' channels (Kim et al. 1995). So 
PDZ domain proteins are thought to be necessary for clustering of transmembrane 
proteins to specific locations in cells.
In a peptide library screening assay it was identified that there is a consensus 
peptide sequence for PDZ domain binding (Songyang et al. 1997). In this consensus it 
was identified that PDZ domains of most of the proteins tend to bind to a hydrophobic 
amino acid at the carboxy terminal end. It was concluded that an internal consensus 
sequence can not bind to PDZ domains even they match perfectly with the obtained 
consensus sequence. However the most important finding in this study is the PDZ 
domains can be divided into two major groups according to their interaction partner 
specificity. According to this finding it was shown that type 11 PDZ domains which are 
the PDZ domains of p55, CASK, Tiam-1, and also AF-6 prefer a hydrophobic residue 
especially a phenylalanine residue at the -2  location from the carboxy terminal end. This 
was against the general belief that PDZ domains préféra hydroxyl group aminoacid like 
serine, threonine, and tyrosine at this specific location. The optimal residues predicted
1.4- PDZ DOMAIN PROTEINS
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by peptide library screening can be rationalized on the basis of crystal structure studies 
performed to identify PDZ domain binding (Doyle et al. 1996).
Structures and binding consensus sequences of some PDZ domain proteins are 
shown in Figure 1.5.
PDZ-1 SH3 4.1 GUK
Z B m 1 1
IBB
Dig
PSD-95
ZO-1
GIu-Ser/Thr-XXX-Val/Ile
CaM-K PDZ-2
&
'TS P « |'''
E 3
CASK
P55
Syntenin
(Glu/Ile)-Phe-(Phe/Tyr)-(Val/Ala)
Figure 1.5: Binding consensus sequences of some PDZ domain proteins
Domain structures of some PDZ domain proteins are shown in the figures. CaM-K: 
Calcium/Calmodulin kinase. 4.1: 4.1 protein binding domain. GUK: Guanylate kinase 
homology domain. Type I PDZ domains bind to a C Terminal consensus sequence of 
Glu-Ser/Thr-XXX-Val/Ile, whereas Type II PDZ domain proteins bind to a C Terminal 
consensus sequence (Glu/Ile)-Phe-(Phe/Tyr)-(Val/Ala) that match perfectly to C 
Terminal amino acid sequences of Syndecan proteins.
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AF-6 protein was identified and cloned as a proto-oncogene in acute myeloid 
leukemia (AML). It was identified to be the fusion partner protein of ALL-1 protein 
caused by a chromosomal translocation [t(6,l)(q23,q27)](Prasad et al. 1993, Saito et al. 
1998). It was observed that this protein contains shared motifs with proteins involved in 
signal transduction, namely PDZ motifs. It was also mapped to minimal deletion region 
in epithelial ovarian cancer but it was shown that AF-6 sequences maps distal to these 
region (Saha et al. 1995). Later drosophila, C. elegans, and mouse homolog of AF-6 
were identified and named as canoe, Ce-AF-6, and afadin respectively (Kuriyama et al. 
1996, Watari et al. 1998, Mandai et al. 1997). Canoe is an important protein for 
drosophila development and is involved in Notch signaling (Miyamoto et al. 1995).
AF-6 contains a putative Ras binding domain, which shows great homology to 
Raf-Ras activating domain. It was shown to bind to Ras protein and another PDZ 
domain protein, ZO-1 in vivo. Unlike p-catenin, AF-6 is localized to tight junctions of 
epithelial cells and ZO-1 is known to be an important component of this type of cell-cell 
junctions (Yamamoto et al. 1997). Ras binding property of AF-6 is regulated with its 
ZO-1 interaction and activated Ras disturbs AF-6 localization to tight junctions. Its 
localization at junctional cell-cell contact sites is also confirmed by showing AF-6 
interaction with JAM (Junctional Adhesion Molecule) (Ebnet et al. 2000).
AF-6 was shown to bind to GTP-activated Ras but not to mutant Ras which lacks 
Its GTP binding domain. All these data indicate that AF-6 is a potential regulator of Ras
1.5- AF-6 AS A PDZ DOMAIN PROTEIN
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pathway which is an important pathway for determination of cell fate (Yamamoto et al. 
1999).
AF-6 was also shown to bind to cell surface receptor tyrosine kinases (RTK) 
epinephrine receptors, EphB3 via their PDZ like domain. Their interaction with Eph 
receptors is regulated by the phosphorylation of the receptors. It was shown that they are 
phosphorylated in vivo upon binding to epinephrine receptors. Receptor tyrosine kinases 
are important integral membrane proteins involved in signal transduction processes. This 
result also show that PDZ like domains modulate signal transduction like other protein- 
protein interaction domains SH3 and PTB (Hock et al. 1998).
A very important finding about AF-6 came only recently reporting that AF-6 
co-localizes and interacts with deubiquitinating enzyme FAM, the human homolog of 
drosophila faf protein (Taya et al. 1998, Kanai-Azuma et al. 2000). Drosophila homolog 
of FAM, faf (fat facets) is known to be an important protein in developmental processes. 
This enzyme regulates the signal transduction events by regulating libiquitination of 
some proteins. FAM and faf probably are involved in stabilization of proteins by 
inhibiting the ubiquitination and therefore degradation. The importance of ubiquitination 
pathway in signaling events is reported for Wnt pathway. It is shown that P-catenin is 
stabilized by deubiquitination enzyme FAM and it can be protected from GSK induced 
degradation (Taya et al. 1999). This may be a potential pathway by which these type of 
signaling events are modulated. This shows that AF-6 is also regulated by a similar 
pathway.
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1.6-HYPOTHESIS
PDZ domain containing proteins play an important role in signaling events as 
cytoplasmic modulators of signaling pathways. They all localize to specific peripheral 
membrane locations like post-synaptic complexes, cell to cell adhesion locations, and 
tight junctions via protein-protein interactions of their PDZ domains. It is known that 
they bind to carboxy terminal of different integral membrane proteins via these domains. 
They are thought to modulate the formation of such complexes and localize integral 
membrane proteins to such locations. Many important PDZ domain containing proteins 
are known to involve in signaling events, Dsh, PSD95 and AF-6 are some of them.
Syndecans are integral membrane proteoglycans that are involved in signaling 
events. They interact with various cellular proteins via their core proteins. Some of these 
proteins are PKC and CASK. We hypothesize that, Syndecan proteins which are known 
to bind to two PDZ domain containimi proteins (CASK and syntenin) may bind to other 
similar proteins such as Dsh and AF-6, since their consensus binding sequence match 
perfectly with the carboxy terminal of Syndecan family of proteins (EFYA).
It was recently reported that Syndecan-1 is involved in Wnt induced 
tumorigenicity in mammary cancer (Alexander et al. 2000). This report was the first 
finding suggesting that a Syndecan protein is involved in tumorigenesis. It is obvious 
that core protein interactions of Syndecan-1 may be important in this and other possible 
functions of Syndecan-1. CASK is a recently identified transcriptional activator (Hsueh 
et al. 2000). Although terminal cytoplasmic region of Syndecan-2, which is responsible 
for the CASK-PDZ domain interaction is identical to the same region of Syndecan-1 
there is no direct evidence yet, that Syndecan-1 binds to CASK protein. AF-6 is shown
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there is no direct evidence yet, that Syndecan-1 binds to CASK protein. AF-6 is shown 
to localize to nucleus as a fusion partner of MLL gene product but the importance of this 
localization is not identified yet (Joh et al. 1997). AF-6 protein has type IIPDZ domain 
like CASK and syntenin which is the Syndecan-2 protein interacting domain. According 
to our hypothesis that all Syndecan proteins bind to type II PDZ domain containing 
proteins, we predicted that Syndecan-1 interacts with PDZ domains o f CASK and AF-6 
through its cytoplasmic domain. To test this hypothesis we used Yeast two-hybrid assay 
to identify Syndecan-1 cytoplasmic domain with PDZ domains o f CASK and AF-6.
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2- MATERIALS AND METHODS
2.1- Recombinant DNA manipulation techniques
2.1.1- Polymerase Chain Reaction (PCR)
Syndecan-1 cytoplasmic domain, CASK-PDZ domain, and AF-6-PDZ domain 
were amplified by polymerase chain reaction using Human Fetal Brain cDNA as 
template.
A standard 100 ul reaction set up in a 0.2 ml PCR tube
primers 0.1-1 uM of each primer (reverse and forward)
dNTP 0.2 mM diluted from the 10 mM stock
buffer IX diluted from the lOX stock
template 10 ng of genomic or plasmid DNA
Made up to 100 ul with MilliQ water
enzyme 2.5 unit of Taq DNA polymerase
Tubes were placed on ice. To perform a hot-start PCR the thermal cycler
was preheated to approximately 90°C before placing the tubes into it. Reaction 
conditions were as follows: Dénaturation: 30 seconds at 94 "C, Annealing: 30 seconds at 
60 "C, Extension: 30 seconds at 72 ”C, 35 cycles.
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List of the synthetic oligonucleotide primer sets used in this study are 
summarized in Table 2 ,1.
Table 2.1: List of the synthetic oligonucleotide primer sets used in this study
name of the 
primer
sequence
(5’-3’)
size
Sn-1026 CATGGCCATGGGGCTGTACCGCATGAAGAAGA 32
Sn-1143 CCGGGTCGACCGCGTCAGGCATAGAATTCC 30
Cs-1476 TCTCCGGATCCCCAATGTGACCAGAGTTCGGCT 33
Cs-1761 TCTCCCTCGCGACAGGACGAAGACTGAGTGC 31
Af-2925 TAGCCGGATCCCGCGTGAGAACACAGAGCTGG 32
Af-3268 AAAAAGAGCTCGCTGATTGAGAAGGGTGG 29
2.1.2- Purification of DNA
Purification of PCR products and linearized plasmids were done either as 
described below or by the MBI DNA extraction kit (#K0513) according to the 
manufacturer’s instructions.
PCR products were purified by precipitating the DNA with ammonium acetate. 
1/10 volume of lOX STE buffer, equal volume of 4M ammonium acetate and 2.5 
volume of 100% (v/v) ethanol were added to the PCR products sequentially. The 
reaction tube was centrifuged at 13000 rpm for 20 minutes at room temperature to pellet 
DNA. The supernatant was removed carefully and discarded. The pellet was washed
with 200 111 of 70% (v/v) ice-cold ethanol. The pellet was dried and DNA was 
resuspended by using TE buffer.
2.1.3- Restriction enzymes
DNA restriction reactions were carried out in a total volume of20-100 ul with 5- 
10 units of restriction enzyme, lul of boiled RnaseA (Img/ml) was used where 
appropriate. The volume of the reaction buffers were arranged to be 1X and the enzyme 
volume was never greater than 1/10th of the reaction volume so as to prevent star 
activity due to the high glycerol concentration. Restriction enzymes used in this study 
are shown in Table 2.2.
Table 2.2: Restriction enzymes used in this study
Enzyme Catalog # Optimized Buffer % of Reactivity in 
V^/Tango Buffer
5a/wHI MBI#ER0051 Buffer BamHI'^ 50-100
Ncol MBI#ER0572 Buffer YVTango 100
S ad MBI#ER1132 Buffer Sacr 20-50
Sail MBI#ER0641 Buffer O' 50-100
Xho\ MBl#ER0691 Buffer R' 100
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2.1.4- DNA ligation
DNA fragments, that were cut from agarose gel and recovered by MBl DNA 
extraction kit (#K0513) were used for ligation. For cloning (where both vector and 
insert DNA has protruding ends) approximately 1 ;4 ratio of vector and insert DNA was 
mixed with the T4 DNA ligase buffer and 1 to 3 units of T4 DNA ligase (MBI 
#EL0011). The reaction was carried out either for 2 hours at room temperature or for 16 
hours at 16°C. For protruding end ligation insert;vector ratio could be chosen as 1/1,2/1,
or 3/1. The reaction was stopped directly by heating at 65°C for 10 minutes or directly 
used to transform competent bacterial cells.
2.1.5- Culturing and handling bacteria
2.1.5.1- Bacterial strains
Strains oiE.coli used in this study are summarized in Table 2.3. 
Table 2.3: Strains of E.coli used in this study
Strain genotype usage reference
DH5a supEAA A/ncU169 
{i^macZAM  15) hs(iR\ 1 recA 1 
endA\ gyrA96 thi-\ relAl
Host for plasmid 
DNA
Hanahan(1983)
HBlOl supE44 hsdS20{ryi mn') recA 13 ara- 
\4 proA2 lacYl galK2 rpsLlO xyl-5 
mtl-\
Host for plasmid 
DNA
Boyer and 
Rouland- 
Dussoix (1969); 
Bolivar an 
Backman 
(1979)
JM  109 ? [iralB6 lacf<\ lacZAM\5 
pro A H ] recA 1 end A 1 gyrA 96 
{NaEj thi hsdR17(r/^m·*·/;;) 
supE44 relA 1 ihi A{lac-proA/i)
Host for plasmid 
DNA
Yanisch-Perron 
et al. (1985)
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2 .1.5.2- Storage of bacteria
Strains of E.coli were stored in glycerol (long term storage). Glycerol cultures of 
E.coli were prepared by adding 0.81 ml of fresh culture to 0.91 ml of sterile 80% 
glycerol in a sterile screw capped tube. The tubes were vortexed and were then frozen 
and stored at -70°C.
2.1.5.3- Growth of E. coli strains
All strains were grown in LB medium or on LA medium supplemented with the 
appropriate antibiotics.
Solid and liquid mediums:
LB medium : 0.5% Yeast extract, 1% Bacto-tiyptone, 1% NaCl.
LA medium ; 0.5% Yeast extract, 1% Bacto-tryptone, 1% NaCl and 1% agar. 
Supplemented with appropriate antibiotics.
Antibiotics:
Ampicillin with a final concentration of 50 ug/ml was used in this study.
2.1.5.4- Preparation of competent bacteria
Cells were made competent using a modification of the CaCl2 method described
by Maniatis et al., 1982.
5 ml LB was inoculated using a single colony from a freshly grown plate of the
li. coli strain to be used, and was incubated at 37^C for approximately 2 hours, until the 
ODeoo of the culture is 0.3-0.4. The culture was then cooled on ice for 5 minutes, 1 ml 
aliquots were added to microcentrifuge tubes and then the cells were pelleted by 
centrifugation (1 minute at 13,000 rpm ). The cells were resuspended in 0.5 ml of 50 
mM CaCh by gentle vortexing, before being placed on ice for 30 minutes. The cells
2X
were pelleted by centrifugation (1 minute at 13,000 rpm ), and the supernatant was 
discarded. The pellet was resuspended in 0.1 ml of CaCb with gentle vortexing. The
cells were then stored on ice until required for transformation. Alternatively competent
cells were prepared and stored at -70°C until required. 500 ml of LB was seeded with a 
10 ml of overnight culture and grown to an OD5 0 0 -  0-6. Cells were harvested by
centrifugation at 5000 rpm for 10 minutes at 4®C, before being incubated on ice for 20 
minutes. The cells were harvested as before, resuspended in 25 ml of 50 mM CaCb
/20% glycerol and aliquoted into microcentrifuge tubes before being frozen. Samples
were stored at -70°C and were viable for at least 2 months. Cells were thawed on ice 
prior to the addition of DNA.
2.1.5.5- Transformation of plasmid DNA in bacterial cells
The DNA to be transformed (usually a 1 ul of ligation mixture or approximately 
100 ng of plasmid DNA) was added to the 100 ul of competent cells, mixed gently and
incubated on ice for 30 minutes. The cells were then heat-shocked at 42^C for 90 
seconds and chilled by placing on ice for 2 minutes. 1 ml of pre-warmed LB was then
added and the suspension was incubated at 37°C for 1 hour. Each sample was pelleted 
by centrifugation at 13,000 rpm for 2 minutes, resuspended in 100-200 ul of LB and
plated onto selective medium and incubated overnight at 37^C to allow the growth of 
the transformants.
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This protocol is based on the alkaline lysis method of Birnboim and Doly
(1979).
The transformed bacterial strain containing the plasmid of interest was grown at
37®C overnight in 5 ml of LB+antibiotic. 1.5 ml of the bacterial culture was pelleted by 
centrifugation for 1 minute (bench-top microfuge, 13,000 rpm) in a 1.5 ml microfuge 
tube. After the removal of the supernatant, the cells were resuspended in 0.1 ml of ice- 
cold solution I and stored for 5 minutes at room temperature. 0.2 ml of solution II was 
mixed by inversion, the tube was then stored on ice for 5 minutes. Bacterial 
chromosomal DNA and proteins were precipitated by the addition of 0.15 ml of ice-cold 
solution HI. The mixture was left on ice for 5 minutes, then centrifuged at 13000 rpm in 
a bench-top centrifuge for 5 minutes to pellet the host DNA and proteins. The 
supernatant was mixed with an equal volume of phenol-chloroform (1:1) and 
centrifuged in a bench-top microfuge at 13000 rpm for 3 minutes to separate the two 
phases. The top phase was removed and plasmid DNA was precipitated by mixing it 
with 2.5 volumes of 95% ethanol, and pelleted by centrifugation for 10 minutes (bench-
top microfuge, 13,000 rpm) after keeping the mixture at 4°C for 15 minutes. The 
supernatant was discarded and the pellet was left for 15-20 minutes at room temperature 
to dry and then resuspended in 20-30 ul of TE buffer containing 10 ug/ml RNaseA.
Samples were stored at 4°C.
2.1.6- Isolation of plasmid DNA from bacteria
2.1.6.1 - Small scale preparation of plasmid DNA
Solution I
50 mM glucose
25 mM Tris Cl (pH 8.0)
10 mM EDTA (pH 8.0)
Solution I can be prepared in batches of approximately 100 ml, autoclaved for 15 
minutes at 10 Ib/square in. on liquid cycle, and stored at 4°C.
Solution II
0.2 NaOH (freshly diluted from 10 N stock)
1%SDS 
Solution III
5 M potassium acetate 60 ml 
glacial acetic acid 11.5ml
H2 O 28.5 ml
The resulting solution is 3 M with respect to potassium and 5 M with respect to acetate. 
TE buffer
pH 7.4 lOmMTris Cl (pH 7.4)
ImMEDTA (pH 8.0)
2.1.6.2- Medium scale purification of plasmid DNA
All midi-preparations were carried out by using the kit supplied by Macherey- 
Nagel (cat # 740 573) according to the manufacturer’s instructions.
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The bacterial strain containing the plasmid of interest was first grown in a 30 ml 
culture with necessary antibiotic until late log phase (OD5 0 0  of 0 .6 ) then inoculated into
500 ml LB medium for 10-12 hours. The cells were harvested by centrifugation at 4000
rpm for 15 minutes at 4°C in a Sorvall GS3 rotor (or equivalent). The supernatant was 
discarded and allowed to drain away in a upside down position.
2.1.6.3.I- Lysis by alkali
This protocol is based on the alkaline lysis method ofBimboim and Doly (1979) 
and the solutions were described above in the mini preparation section. The bacterial 
pellet was resuspended and washed in 18 ml solution I.
40 ml o f freshly prepared solution II was added, the lid of centrifuge tube was 
closed and the bottle was inverted several times. The bottle was kept at room 
temperature for 5-10 minutes.
20 ml of ice cold solution IH was added, the lid of the bottle was closed and 
shaked several times. The bottle was stored on ice for 10 minutes.
The cell lysate was centrifuged at 4000 rpm for 15 minutes at 40C. The rotor was 
stopped without braking.
The supernatant was filtered through 4 layers of cheesecloth into a 250 ml 
centrifuge bottle. 0.6 volume of isopropanol was added and mixed well, in order to 
precipitate the nucleic acids. The bottle was kept at room temperature for 10 minutes.
Nucleic acids were recovered by centrifugation at 5000 rpm for 15 minutes at 
room temperature in a Sorvall GS3 rotor (or equivalent). Salt may precipitate if the
centrifugation is performed at 4°C. The supernatant was poured off gently and the bottle
2.1.6.3- Large scale purification of plasmid DNA
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bottle was inverted so as to allow all fluid to drain away. The pellet and the walls of the 
bottle was washed with 70% ethanol at room temperature. After draining off ethanol, 
by the help of a Pasteur pipette attached to vacuum, beads of liquid that were attached to 
the walls of the bottle were removed. The inaccessible ethanol was left to evaporate at 
room temperature. The pellet was dissolved in 3 ml of TE (pH 8.0).
2.1.7- Quantification of double stranded DNA
The amount of DNA in samples were determined by reading the absorbency of 
the samples at 260 nm. An OD260 of 1 corresponds to a concentration of 50 ug/ml for 
double stranded DNA, 40 ug/ml for single stranded DNA and 20 ug/ml for 
oligonucleotides (Maniatis e ta l,  1982).
2.1.8- Plasmids
Plasmids used in this study are listed in Table 2.4. All plasmids are yeast vectors 
designed for expression of exogenous genes in yeast. They also contain P-lactamase 
gene serving as ampicillin resistance gene in order to amplify and store them in bacteria.
Table 2.4: List of Plasmids used in this study
pAS2-l 8.4-kb cloning vector; used to generate fusion of the bait protein with the 
GAL4 DNA-BD.
pACT2 8.1-kb cloning vector; used to generate fusion of a known protein (or a 
collection of random, unknown proteins) with the GAL4 AD.
pVA3-l 9.4-kb positive control plasmid used with pTDl-1; encodes a DNA- 
BD/murine p53 fusion protein in pAS2-l.
pTDl-1 9.9-kb positive control plasmid used with pVA3-l; encodes an AD/SV40 
large T-antigen fusion protein in pACT2.
pC L l 15.3-kb positive control plasmid; encodes the full-length, wild-type GAL4 
protein.
pLAM 5’- l 9.1-kb false-positive detection plasmid; encodes a DNA-BD/human lamin 
C fusion protein in pAS2-l.
2.2- Yeast two-hybrid system
Yeast two-hybrid assay was used in this study to show Syndecan-1 interaction 
with PDZ domains of CASK and AF-6. Yeast two-hybrid assay was chosen since it is a 
recently developed, powerful, and easily used protein assay which is frequently used in 
similar studies (Fields & Song 1989, Frederickson 1998). MATCHMAKER Two- 
Hybrid System 2 (#K 1604-1) was used which is a GAL4 based two-hybrid system that 
provide a transcriptional assay for detecting specific protein-protein interactions in yeast. 
Yeast two-hybrid system is either used to screen a cDNA library to identify unknown
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interactions among the total population of cellular proteins, or it is used to detect specific 
protein-protein interactions between two known proteins.
Yeast two hybrid system is based on the fact that many eukaryotic transacting 
transcription activators are composed of separable, functionally distinct and independent 
domains. These domains are usually DNA binding domain (BD) that recruits the 
transcription factor to specific DNA sequences and transactivating domain (AD) that 
interacts with RNA polymerase II complex and initiates transcription. GAL4 is a yeast 
transcription factor composed of these two (BD and AD) domains. When these two 
domains are separated from each other by recombinant DNA techniques and expressed 
in the same cell they can not bind to each other and form a functional transcription 
factor. However these two domains can be placed in close proximity by the means of 
protein-protein interaction and functional transcriptional factor can be formed. Reporter 
gene expression can be obtained by such means, hence the reporter gene expression can 
be utilized as an indicator of protein-protein interaction. In MATCHMAKER system 
two functional domains of GAL4 transcription factor is supplied in two different yeast 
expression vectors such that two domains of GAL4 can be expressed as two fusion 
proteins in yeast. One of the vectors (pAS2-l) express DNA binding domain of GAL4 
protein which binds to DNA at specific sequences. The other vector expresses 
transactivating domain of GAL4 protein which activates the transcription of the genes 
by interacting with transcription machinery.
Two different proteins can be cloned in these two vectors fused to BD and AD of 
GAL4. So that upon the interaction between these proteins reporter gene activation can 
be detected. A schematic representation of yeast two-hybrid assay is shown in the 
following figure. (Figure 2 .1 )
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Figure 2.1 : Yeast two-hybrid assay
Schematic representation of yeast two-hybrid assay. Protein-protein interaction between 
Protein X and Protein Y leads to construction of functional GAL4 transcription factor. 
Which can transactivate a reporter gene (ß-galactosidase) under the control of GAL4 
promoter sequence.
2.2.1- Strains of Yeast
The Saccharomyces cerevisiae strains used in this study and their specifications 
are listed in Table 2.5.
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The GAL I upstream activating sequence (UAS) and the three tandem copies of the 
GAL4 17-mer consensus sequence [GAL4 i7-mors(x3)] are both responsive to the GAL4 
transcriptional activator. The trp 1, leu2 , his3, gal4 and gal80 mutations are all deletions.
Table 2.5: Yeast strains used in this study
Strain Genotype Reporter T ransforniation 
markers
Y187 MATa, ura3-52, his3-200, ade2-101, 
trp 1-901, leu2-3, 112, gal4A, mef, 
galSOA,
URA3 ..GAL 1 u.xs-GAL 1 xAT.ylacZ
lacZ
(high)
trp l, leu2
Y190 MATa, ura3-52, his3-200, lys2-801, 
ade2-101, trp l-901, leu2-3,112, gal4A, 
cyh"2 ,
LYS2::GAL1 UAS- fflS3T.\TA-fflS3 
URA3 :;GALluAS~GALİTATA~lacZ_____
fflS3
(leaky),
lacZ
(high)
trpl, leu2 , 
cyh' 2^
CG1945 MATa, ura3-52, his3-200, }ys2-801, 
ade2-101, trp l-901, leu2-3,112, gal4A, 
cyh''2 ,
LYS2;;GAL1 UAS- GALİ TATA- fflS3
URA3 ..OAL4|7-mers(x3)~^y^ ^  T.AT.A’lacZ
fflS3 (less 
leaky), 
lacZ 
(low)
tip l, leu2 , 
cyh^2
2.2.2- Storage of yeast
Yeast strains were stored in YPD medium with 25% glycerol at -70"C. 
Transformed yeast strains were stored in the appropriate SD medium to keep selective 
pressure on the plasmid. To recover frozen strains, a small portion of glycerol stock was 
streaked onto YPD or appropriate SD agar plate.
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2.2.3- Growth of yeast
Yeast strains were grown in liquid YPD medium or appropriate SD medium for 
preparing liquid cultures. They were grown on solid media by using YPD-Agar plates or 
SD-Agar plates according to their transformation status.
YPD medium:
20 g/L Difco peptone
10 g/L Yeast extract
20 g/L Agar (for solid media only)
950 ml of H2O is added and pH is adjusted to 5.8 and autoclaved.
After cooling glucose was added to a final concentration of 2% as carbon source.
SD medium:
6.7 g Yeast Nitrogen Base without amino acids 
20 g Agar for solid media only 
850 ml H2O
100 ml of the appropriate sterile lOX dropout solution
pH is adjusted to 5.8 and autoclaved. After cooling glucose was added to a final 
concentration of 2 % as carbon source. 
lOX D ropout (DO) supplements:
Filter sterilized solution of the following amino acids in H2O (Table 2.6).
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Table 2 .6 : Dropout (DO) supplements
L-lsoleucine 300 mg/L 1-7383
L-V'aline 1500 mg/L V-0500
L-Adenine hemisulfate salt 200 mg/L A-9126
L-Arginine HCl 200 mg/L A-5131
L-Methionine 200 mg/L M-9625
L-Phenylalanine 500 mg/L P-5030
L-Threonine 2000 mg/L T-8625
2.2.4- Transformation of Plasmid DNA into Yeast using LiAc method
1 ml of YPD or SD was inoculated with several colonies of yeast, 2-3 mm in 
diameter and was vortexed for 5 minutes to disperse any clumps. For host strains 
previously transformed with another autonomously replicating plasmid, the appropriate 
SD medium was used. This was then transfeired into a flask containing 50 ml of YPD or 
the appropriate SD medium. It was incubated at 30°C for 16-18 hr with shaking at 250 
rpm to stationary phase (ODeoo >1.5). 30 ml of the overnight culture was then transferred 
to a flask containing 300 ml of YPD.
This culture was incubated at 30°C for 3 hr with shaking (230 rpm). At this 
point, the ODgoo was 0.4-0.6 . Cells were placed in 50-ml tubes and centrifuged at 1 ,0 0 0  
X g for 5 min at room temperature (20-21°C). Supernatant was discarded and 25-50 ml 
of sterile ТЕ or distilled H2O was added to the tube. Resuspended thoroughly by 
vortexing. Cells were pooled in one tube and centrifuged at 1 ,0 0 0  x g for 5 min at room 
temperature. Supernatant was discarded.
V)
Cells were resuspended in 1.5 ml of freshly prepared, sterile 1X TE/1X LiAc. 0.1 
mg of plasmid DNA and 0.1 mg of Salmon testes carrier DNA (Sigma #D-9156) was 
added to a fresh 1,5-ml tube and mixed. 0.1 ml of yeast competent cells were added to 
each tube and mixed well by vortexing. Then 0.6 ml of sterile PEG/LiAc solution was 
added to each tube and vortexed at high speed for 10 sec to mix. Incubated at 30°C for 
30 min with shaking at 200 rpm. 70 ul o f DMSO was added. Mixed well by gentle 
inversion. Heat shocked for 15 min in a 42°C water bath. Cells were then chilled on ice 
for 1 - 2  min.
Cells were centrifuged for 5 sec at 14,000 rpm at room temperature. The 
supernatant was removed and were resuspended in 0.5 ml of sterile IX  TE buffer. Plated 
100 ul on each SD agar plate that would select for the desired transformants.
PEG/LiAc Solution:
PEG 3350 (Sigma #P-3640) 40%
TE Buffer IX
LiAc 0.1 M
p H ; 7.5
2.2.5- Colony-lift filter assay
Fresh colonies were used (i.e., grown at 30°C for 2-4  days), 1-3 mm in 
diameter. Z buffer/X-gal solution was prepared freshly as described below.
For each plate of transformants that were assayed, a sterile Whatman #5 or VWR 
grade 410 filter was presoaked by placing it in 2.5-5 ml of Z buffer/X-gal solution in a 
clean 100- or 1 50-mm plate.
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Using forceps, a clean, dry filter was placed over the surface of the plate of 
colonies that were assayed. The filter rubbed gently with the side of the forceps to help 
colonies cling to the filter. Holes poked through the filter into the agar in three or more 
asymmetric locations to orient the filter to the agar. When the filter had been evenly 
wetted, it was carefully lifted off the agar plate with forceps and transferred (colonies 
facing up) to a pool of liquid nitrogen. Using the forceps, it was completely submerged 
for 10  sec.
After the filter had frozen completely (~10 sec),it was removed from the liquid 
nitrogen and allowed to thaw at room temperature. (This freeze/thaw treatment is to 
permeabilize the cells.)
The filter was carefully placed, colony side up, on the presoaked filter. Trapping 
of air bubbles under or between the filters was avoided. The filters were incubated at 
30°C (or room temperature) and checked periodically for the appearance of blue 
colonies. The time it took colonies producing p-galactosidase to turn blue varied, from 
30 min to 8  hr.
The P-galactosidase-producing colonies were identified by aligning the filter to 
the agar plate using the orienting marks. The corresponding positive colonies from the 
original plates were picked to fresh medium. If the entire colony was lifted onto the 
filter, the original plate was incubated for 1 - 2  days to regrow the colony.
2.2.6- Liquid Culture Assay Using ONPG as Substrate
5 -ml overnight cultures were prepared in liquid SD selection medium appropriate 
for our system and plasmids. On the day of the experiment, ONPG was dissolved at 4
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mg/ml in Z buffer with shaking for 1-2 hr. The overnight culture tube was vortexed for 
0.5—1 min to disperse cell clumps. 2 ml of the overnight culture was immediately 
transferred to 8 ml of YPD. The fresh culture was incubated at 30°C for 3-5 hr with 
shaking (230-250 rpm) until the cells were in mid-log phase (ООбоо of 1 ml = 0.5-0.8). 
The exact ODooo when the cells were harvested was recorded. Before checking the OD, 
the culture tube was vortexed for 0.5-1 min to disperse cell clumps.
1.5 ml of culture was placed into each of three 1.5-ml microcentrifuge tubes. 
Centrifuged at 14,000 rpm (10,000 x g) for 30 sec. Supernatants were carefully removed.
1.5 ml of Z buffer was added to each tube and vortexed until cells were resuspended. 
Cells were centrifuged again and supernatants removed. Each pellet was resuspended in 
300 ul o fZ  buffer. (Thus, the concentration factor is 1.5 /0.3 = 5-fold).
0.1 ml of the cell suspension was transferred to a fresh microcentrifuge tube. The 
tubes were placed in liquid nitrogen until the cells were frozen (0.5-1 min). Frozen tubes 
were placed in a 37°C water bath for 0.5-1 min to thaw. Freeze/thaw cycle was repeated 
for two more times to ensure that the cells have broken open.
A blank tube was prepared with 100 ml of Z buffer. 0.7 ml of Z buffer-P- 
mercaptoethanol was added to the reaction and blank tubes.
160 ml of ONPG in Z buffer was added immediately to the reaction and blank 
tubes. Tubes were placed in a 30°C incubator.
After the yellow color developed, 0.4 ml of 1 M Na2CO? was added to the 
reaction and blank tubes. Elapsed time was recorded in minutes. Reaction tubes were 
centrifuged for 10 min at 14,000 rpm to pellet cell debris. Supernatants were carefully 
transferred to clean cuvettes. The spectrophotometer was calibrated against the blank at
A420 and the OD420 of the samples were measured relative to the blank. P-galactosidase 
units were calculated. 1 unit of b-galactosidase is defined as the amount which 
hydrolyzes 1 mmol of ONPG to o-nitrophenol and D-galactose per min per cell (Miller, 
1972; Miller, 1992);
p-galactosidase units = 1,000 x OD420 /(t x V x ODôoo ) 
where; t = elapsed time (in min) of incubation 
V = 0.1 m ix concentration factor 
ODeoo =Абоо of 1 ml of culture
Z Buffer:
Na2HP04. 7H2O
НаНгР04 .  H2O 
KCl
16.1 g/L
5.50 g/L 
0.75 g/L
0.246 g/LMgS04 · 7 H2O 
pH adjusted to 7.0 and autoclaved 
X-gal Stock solution:
5-bromo-4chloro-3-inodyl-b-D-galactopyranoside (X-GAL; Sigma #) was dissolved in 
N,N-dimethylformamide (DMF) at a concentration of 20 mg/ml. Stored in dark and at 
-2 0  ''C.
Z Buffer/ X-gal solution:
Z buffer '00  ml
P-mercaptoethanol (b-ME; Sigma #M-6250) 0.27 ml
X-gal solution ' 07 ml
prepared freshly before use.
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Z bufler-p-mercaptoethanol:
To 100 ml of Z buffer, 0.27 ml of p-mercaptoethanol was added.
ONPG (o-nitrophenyl p-D-galactopyranoside) solution:
Prepared freshly before use. 4 mg/ml o-nitrophenyl p-D-galactopyranoside (sigma #N- 
1127) was added to Z buffer. pH was adjusted to 7.0 and mixed.
2.2.7- Purification of total protein from yeast
2.2.7.1- Preparation of yeast cultures for protein extraction
For each transformed yeast strain, a 5-ml overnight culture was prepared in SD 
selection medium. A single isolated colony (1-2 mm in diameter, no older than 4 days) 
was used. Overnight cultures were vortexed for 0.5-1 min to disperse cell clumps. For 
each clone to be assayed (and the negative control), the entire overnight culture was 
separately inoculated in 50-ml aliquots of YPD medium. Incubated at 30°C with shaking 
(220-250 rpm) until the ODr,oo reached 0.4-0.6.
ODeoo (of a 1-ml sample) is multiplied by the culture volume (i.e., 55 ml) to 
obtain the total number of ODeoo units.
The culture was quickly chilled by pouring it into a prechilled 100-ml centrifuge 
tube halfway filled with ice. Tubes were immediately placed in a prechilled rotor and 
centrifuged at 1000 x g for 5 min at 4°C. Supernatants were discarded and cell pellets 
were resuspended in 50 ml of ice-cold H2O. The pellets were recovered by 
centrifugation at 1,000 x g for 5 min at 4°C. The cell pellets were immediately frozen by 
placing the tube on dry ice or in liquid nitrogen. Cells were stored at -70°C until usage.
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1.2.1.2- Preparation of protein extracts by Urea/SDS method
Complete cracking buffer was prepared and prewarmed to 60°C. 100 ml of 
cracking buffer was used per 7.5 ODwm units of cells. Cell pellets were quickly thawed 
by separately resuspending each one in the prewarmed cracking buffer.
Each cell suspension was transferred to a 1.5-ml screw-cap microcentrifuge tube 
containing 80 ml o f glass beads per 7.5 ODeoo units of cells. Samples were heated at 
70°Cfor 10 min.
Samples were vortexed vigorously for 1 min. Cell debris and unbroken cells 
were pelleted in a microcentrifuge at 14,000 rpm for 5 min, at 4°C. The supernatants 
were transferred to fresh 1.5-ml screw-cap tubes and placed on ice (first supernatants). 
Pellets were treated as follows:
a. Tubes were placed in a 100°C (boiling) water bath for 3-5 min.
b. Vortexed vigorously for 1 min.
c. Debris and unbroken cells were pelleted in a microcentrifuge at 14,000 rpm for 5 min, 
at 4°C.
d. This supernatant (second supernatant) was combined with the corresponding first 
supernatant.
The samples were boiled briefly. Immediately loaded on a gel. Alternatively, 
samples were stored on dry ice or in a -70°C freezer until they were runned on a gel. 
Protease inhibitor solution(stock):
Pepstatin A Sigma #P4265 0.1 mg/ml (for Carboxyl proteases)
Leiipeptin Sigma #L2884 003 mM (for some thiol and serine proteases)
Benzamidine Sigma #86506 145 mM (for trypsin, plasmin, and thrombin)
Aprotiniii Sigma #A6279 0.37 mg/ml (for some serine proteases)
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PMSF:
0.1742 g PMSF (Sigma #P7626) was dissolved in ! 0 ml isopropanol.
Glass Beads:
425-600 |im acid washed glass beads (Sigma #G-8772)
Cracking Buffer (stock solution):
Urea 8 M
SDS 5% (w/v)
Tris-HCl[pH6.8] 40 mM
EDTA 0.1 mM
Deionized H2O to a final volume of 100 ml 
Cracking Buffer (complete solution):
Cracking Buffer stock solution 1 ml 
p-mercaptoethanol 10 p.1
Protease inhibitor solution 70 pi
PMSF  ^ stock
used freshly.
2.3- Constructs
Syndecan-1 PCR product was cloned in pAS2-l using Sail and Ncol enzymes, 
such that it is expressed as fusion protein with GAL4 BD. CASK PDZ and AF-6 PDZ 
PCR products were also cloned in pACT2 such that they are expressed fiised to GAL4 
AD. Enzymes used to clone CASK-PDZ domain were BamHl and Xhol. BamHl and
46
Sad enzymes were used to clone AF-6-PDZ domain. Schematic representation of 
recombinant proteins are presented in Figure 2.2.
GAL4 BD Syl Cyt. 1
GAL4 AD CASK PDZ
GAL4AD AF-6 PDZ
Figure 2.2: Schematic representation of recombinant proteins
2.4- Sequencing of DNA
Sequencing of plasmid DNA was performed by automated ABI PRISM™ 377 
DNA Sequencer, Perkin Elmer. Sequencing experiments were performed by Birsen 
Cevher at Bilgen.
2.5- Gel Electrophoresis
2.5.1- Agarose Gel Electrophoresis (AGE)
1 % Agarose (w/v) in TAE buffer was used in all Agarose gel electrophoresis 
experiments.
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TAE biifTer
Tris acetate 0.04 M
EDTA
pH: 7.0
0.001 M
2.5.2- SDS-Polyacrylaniide gel electrophoresis of proteins
The glass plates were assembled according to the manufacturer’s instructions 
(EC). The volume of the gel mold was determined according to the information provided 
by the manufacturer (EC). In an Erlenmeyer flask, the appropriate volume of solution 
containing the 15 % of acrylamide for the resolving gel was prepared.
Without delay, the mixture was swirled rapidly and the acrylamide solution was 
poured into the gap between the glass plates. Sufficient space (the length o f the teeth of 
the comb plus 1 cm.) for the stacking gel was left. The acrylamide solution was overlaid 
by using a Pasteur pipette with isobutanol. The gel was placed in a vertical position at 
room temperature. After polymerization was complete, the overlay was poured off and 
the top of the gel was washed several times with deionised water to remove any 
unpolymerized acrylamide. As much fluid as possible was drained from the top of the 
gel and then any remaining water was removed with the edge of a paper towel.
Stacking gel was prepared in a disposable plastic tube at an appropriate volume 
and at 5% concentration. Without delay, the mixture was swirled rapidly and the 
stacking gel solution was poured directly onto the surface of the polymerized resolving 
gel. The comb was immediately inserted into the stacking gel, being careful to avoid 
trapping air bubbles. The gel was placed in a vertical position at room temperature. 
While the stacking gel was polymerizing, the samples to be loaded were prepared by
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heating them to lOO^C for 10 minutes in IX SDS gel-loading buffer to denature the 
proteins. After polymerization was complete, the comb was removed carefully. By using 
a squirt bottle, the wells were washed with deionized water to remove any 
unpolymerized acrylamide.
The electrophoresis apparatus was attached to an electric power supply and the 
gel was run at a voltage that is approximately 8V/cm, After the dye front has moved to 
the resolving gel, the voltage was increased to 15 V/cm, until the bromophenol blue 
reaches the bottom of the resolving gel. Then the power supply was turned off.
The glass plates were removed from the electrophoresis apparatus and placed on 
a paper towel. By using a spatula, the plates were pried apart. Orientation of the gel was 
marked by cutting a comer from the bottom.
IX SDS gel-Ioading buffer
50 mM Tris Cl (pH 6.8)
1 OOmM dithiothreitol (DTT)
2% SDS (electrophoresis grade)
0.1% bromophenol blue 
10% glycerol
IX SDS gel-loading buffer lacking DTT can be stored at room temperature. 
DTT should be added, just prior to use, from 1 M stock.
Tris-glycine electrophoresis buffer
25 mM Tris
250 mM glycine (electrophoresis grade)
0.1% SDS
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30% mix (Acrylamide and bis-acrylamide solution)
A stock solution of 29% (w/v) acrylamide and 1% (w/v) bis-acrylamide.
Solution was stored in dark bottles at 4°C.
I0% SDS
A 10% (w/v) stock solution was prepared in deionized water
APS
A small amount of 10% stock solution was prepared in deionized water and 
stored at
2.6- Transfer of proteins from SDS-polyacrylamide gels to solid supports
As the SDS-polyacrylamide gel was approaching the end of its run, six pieces of 
Whatman 3MM paper and one piece of transfer membrane (Millipore-Immobilon-P) 
was cut to the exact size of the SDS-polyacrylamide gel by wearing gloves because oil 
and secretions from the skin may prevent the transfer of proteins from the gel. Matching 
of the sizes of these papers and transfer membrane is very important because if the 
paper or membrane is larger than the gel, the overhanging edges of the paper and the 
membrane will touch the charged plates, causing a short circuit that will prevent the 
transfer of protein from the gel. One corner of the membrane was marked with a soft- 
lead pencil.
The membrane was left in methanol for 5 minutes and then washed with 
deionized water and soaked into transfer buffer for 15-20 minutes. Meanwhile the
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Whatman 3MM papers were soaked into a shallow tray containing a small amount of 
transfer buffer and kept shaking for 15-20 minutes.
Wearing gloves, the transfer apparatus was set as follows:
3 layers o f Whatman 3MM paper that have been soaked in transfer buffer was 
put onto the plate which will be negatively charged (cathode). It is important to squeeze 
out any air bubbles.
The transfer membrane was placed onto the Whatman 3MM papers. (The 
transfer membrane should be exactly aligned and the air bubbles trapped between it and 
the Whatman 3MM paper should be squeezed o u t.)
The glass plates holding the SDS-polyacrylamide gel was removed from the 
electrophoresis tank, and the gel was transferred to a tray of deionized water.
SDS-polyacrylamide gel was placed onto the transfer membrane. Any trapped 
air bubbles were squeezed out with a gloved hand.
3 layers o f Whatman 3MM paper were placed to the top of the sandwich (this 
side will be positively charged during the transfer (anode side).)
The upper plate of the apparatus which will be the cathode during the transfer. 
The electrical leads of the apparatus were connected to the power supply and the 
transfer was carried out at a current of 0.65 mA/square. cm of the gel for a period of 1.5- 
2 hours.
The electric current was turned of at the end of the run time and the transfer 
apparatus was disassembled from top downward, peeling off each layer in turn. The gel 
was transferred to a tray containing Coomassie Brilliant Blue and stained in order check 
if the transfer is complete or not. The bottom left-hand comer of the membrane was cut 
as insurance against obliteration o f the pencil mark.
2.7- Staining SDS-polyacrylamide gels with Coomassie Brilliant Blue
Polypeptides separated by SDS-polyacrylamide gels were fixed with 
methanol:glacial acetic acid and stained with Coomassie Brilliant Blue R250.
0.25 g of Coomassie Brilliant Blue R250 was dissolved in 90 ml of methanol;H20 (1 ;1
v/v) and 10 ml of glacial acetic acid. In order to remove any particulate material, the 
solution was filtered through a Whatman No. 1 filter. The gel was immersed in at least 5 
volumes of staining solution and was placed on a slowly rotating platform for a 
minimum of 4 hours at room temperature.
At the end of staining, the stain was removed and saved for future use. The gel 
was destained by soaking in the methanol-acetic acid solution without the dye (90 ml of 
methanol:H20 (1:1 v/v) and 10 ml of glacial acetic acid), on a slowly rotating platform
for 4-8 hours at room temperature, changing the destaining solution three or four times, 
destaining for 24 hours allows as little as 0.1 ug of protein to be detected as a single 
band.
After destaining, gels can be stored indefinitely in water or can be dried.
2.8- Staining proteins immobilized on solid surfaces with Ponceau S
The membrane onto which proteins were transferred was washed with deionized 
water and then soaked into Ponceau S. When bands of proteins become visible, the
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membrane was washed in several changes of deionized water at room temperature. The 
positions of proteins used as molecular-weight standards were marked.
Ponceau S
10% glacial acidic acid 
5% Ponceau S 
dH 20
2.9- Immunological detection of immobilized proteins (Western Blotting)
After staining the proteins immobilized on transfer membrane with Ponceau S, 
the membrane was washed gently with deionized water and neutralized with the 
blocking buffer for 5 minutes. In order to inhibit non-specific binding sites, the 
membrane was immersed in the blocking solution for at least 60 minutes at room 
temperature. Mouse monoclonal antibodies are used in this study (Table 2.7). Primary 
antibody was diluted as recommended by the supplier in blocking solution and was kept 
at room temperature for at least one hour on a slowly rotating platform. Afterwards the 
membrane was washed for three times, once for 15 minutes and twice for 5 minutes, 
with blocking buffer. Following the washes the membrane was incubated in the 
blocking solution containing the secondary antibody (peroxidase-conjugated rabbit anti­
mouse immunoglobulin) diluted as recommended by the supplier for 1 hour and then 
washed for three times, once for 15 minutes and twice for 5 minutes, with the blocking 
buffer. Finally the membrane was washed with deionized water and was ready for 
development.
Blocking Buffer
0.1 % Tween-20 in IX PBS 
Blocking Solution
5% milk powder in 0.1% Tween 20-PBS solution 
IX PBS
8 g NaCl
0.2 g KCl
1.44gNa2HP04
0.24gKH2PO4
Volume was adjusted to 1 liter
pH was adjusted to 7.4
Table 2.7: Antibodies used in this study
Antibody Developer/Cat, #
Anti-GAL4 (DBD) mouse monoclonal IgG:» Santa Cruz Biotech. 
Cat.#Sc-510
Anti-[HA]-peroxidase mouse monoclonal IgG Boehringer-Mannheim 
Cat. #1667 475
Anti-[mouse IgG (H+L)]-peroxidase Boehringer-Mannheim 
Cat. #1814 168
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2.10- Detection of proteins immobilized on membrnnes
Detection of proteins immobilized on membranes were done by using the ECL 
Western Blotting kit (Amersham Pharmacia Biotech.) (Catalog # RPN 2109) according 
to the manufacturer’s instructions.
2.11- Equipment
Instruments which were routinely used in this study are as follows;
Automatic pipettes (Eppendorf), filter and 3MM paper (Whatman), programmable dri- 
block temperature cycler GeneAmp PCR System 9600 (Perkin Elmer), heating blocks 
(Stuarts Scientific), benchtop centrifuge (Heraus Instruments), avanti J-025I centrifuge 
(Beckman),gel tanks for agarose (E-C Apparatus Corporation), vertical protein gel tank 
(E-C Apparatus Corporation), spectrophotometer DU 640 (Beckman), power supply 
(BioRad), pH meter (Beckman), UV transillimunator (Herolab), transferblot SD 
(BioRad).
2.12- Consumables
All chemicals were purchased from Sigma, Difco, or Carlo-Erba. Plastic disposables 
were purchased from Costar, Nunc, or Greiner Scientific.
3- RESULTS
3.1- Cloning of Syndecan-1 cytoplasmic domain in yeast vector pAS2-l
Syndecan-1 cytoplasmic domain was amplified by polymerase chain reaction 
using Human Fetal Brain cDNA as template. Syndecan-1 cDNA sequence was obtained 
from the Genebank (Accession number: NM 002997). Primers were designed to 
amplify the DNA fragment between nucleotides 1026 and 1143. Ncol enzyme 
recognition sequence was attached as a linker upstream of sense primer. Sail site was 
attached upstream of antisense primer. Expected size of the PCR product was 138 base 
pairs. The result of PCR reaction is shown in Figure 3.1.
4
500 base pairs 
250 base pairs
Figure 3.1: PCR amplification of Syndecan-1 cytoplasmic domain
Lane 1: 1 Kb DNA ladder. Lane 2: PCR Syndecan-1, Lane 3: PCR Syndecan-1,
Lane 4: PCR Syndecan-1, Lane 5: PCR Syndecan-1, Lane 6: PCR negative control
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PCR product and pAS2-l vector were double digested with Ncol and Sail 
enzymes. Double cut DNA fragments were then ligated and transformed in bacteria. 
Plasmid DNA was purified from the transformed clones and checked for the presence of 
the insert by double digestion with Ncol and Sail enzymes. Result o f the digestion 
reaction is shown in the following figure (Figure 3.2).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Figure 3.2: Restriction enzyme digestion of Syl-pAS construct 
Lane 1 ,7 ,15: PCR product Syndecan-1 Cytoplasmic domain. Lane 2 ,8 ,1 6 :1 Kb DNA 
Ladder, Lane 3: Uncut clone 1, Lane 4: Cut clone 1, Lane 5: Uncut clone 2, Lane 6: 
Cut clone 2, Lane 9: Uncut clone 3, Lane 10: Cut clone 3, Lane 11: Uncut clone 4, 
Lane 12: Cut clone 4, Lanel3: Uncut clone 5, Lane 14: Cut clone 5, Lane 17: Uncut 
clone 6, Lane 18: Cut clone 6, Lane 19: Uncut clone 7, Lane 20: Cut clone 7, Lane 21: 
Uncut clone 8, Lane 22: Cut clone 8 (Places of inserts are shown by vertical arrows)
Seven of the eight clones (clones 1,2,4,5,6,7, and 8) contained inserts exactly the 
same size with the PCR product of Syndecan-1 cytoplasmic domain (138 base pairs). 
These clones were further confirmed by expression studies.
The positive clones were transformed to the yeast strains and total protein was 
extracted from the transformed yeast strains as explained in the materials and methods
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section. Expression of pAS2-l based constructs (Syl-pAS clones) were checked in yeast 
(strain Y187) by SDS-PAGE followed by western blotting using monoclonal antibody 
against the GAL4 BD. The size of the GAL4 BD is 21.5 kJDa and expected size of the 
GAL4 BD-Syndecan-1 cytoplasmic domain fusion protein is 22.5 kDa. Result is 
presented in the following figure (Figure 3.3):
29.5 kDa
23.5 kDa
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Figure 3.3: Expression of constructs cloned in pAS2-l vector 
Lane 1: Untransformed, Lane 2: Molecular Weight marker. Lane 3: pAS2-l 
transformed. Lane 4: Clone 1 of Syl-pAS transformed. Lane 5: Clone 2 of Syl-pAS
transformed. Lane 6: Clone 4 of Syl-pAS transformed. Lane 7: Clone 5 of Syl-pAS
transformed. Lane 8: Clone 6 of Syl -pAS transformed. Lane 9: Clone 7 of Syl -pAS
transformed. Lane 10: Clone 8 of Syl-pAS transformed (places of fusion proteins are
shown by arrows)
The constructs 1, 5 and 8 expressed expected size of proteins. These constructs 
were further confirmed by DNA sequencing analysis. All three constructs had correct 
DNA sequence. By this way cloning of Syndecan-1 cytoplasmic domain was verified.
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3.2- Cloning of PDZ domain of CASK and AF-6 in yeast plasmid pACT2
PDZ domains of CASK and AF-6 were amplified by polymerase chain reaction 
using Human Fetal Brain cDNA as template. cDNA sequences were obtained from the 
Genebank (Accession numbers: AF032119 for CASK and U02478 for AF-6). Primers 
were designed to amplify the DNA fragments between nucleotides 1476 and 1761 for 
CASK, and 2925 and 3268 for AF-6. BamHI enzyme recognition sequence was attached 
as a linker upstream of sense primer of CASK. Xhol site was attached upstream of 
antisense primer. Expected size of the PCR product was 329 base pairs. The result of 
PCR reaction is shown in Figure 3.4.
500 base pairs 
250 base pairs
Figure 3.4: PCR amplification of CASK PDZ domain
Lane 1: 1 Kb DNA ladder. Lane 2: PCR negative control. Lane 3: PCR CASK PDZ 
domain, Lane 4: PCR positive control (PCR Syndecan-1)
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BamHl enzyme recognition sequence was attached as a linker upstream of sense 
primer of AF-6. S ad  site was attached upstream of antisense primer. Expected size of 
the PCR product was 367 base pairs. The result of PCR reaction is shown in Figure 3.5.
500 base pairs 
250 base pairs
Figure 3.5: PCR amplification of Af-6 PDZ domain
Lane 1: 1 Kb DNA ladder. Lane 2: PCR Af-6 PDZ domain. Lane 3: PCR Af-6 PDZ 
domain. Lane 4: PCR CASK PDZ domain. Lane 5: PCR negative control
PCR products and pACT2 vector were double digested with BamFII and Xhol 
for CASK, and BamHl and S ad  for AF-6. Double cut DNA fragments were then ligated 
and transformed in bacteria. Plasmid DNA’s were purified from the transformed clones 
and checked for the presence of the insert by double digestion with corresponding 
enzymes. Results of the digestion reactions are shown in the following figures (Figure 
3.6, Figure 3.7).
6 0
500 base pairs 
250 base pairs
*
Figure 3.6: Restriction enzyme digestion of Csk-pACT construct 
Lane 1: Uncut pACT2, Lane 2: 1 Kb Ladder, Lane 3: Cut clone 1, Lane 4: Cut clone 
2, Lane 5: Cut clone 3, Lane 6: Cut clone 4, Lane 7: Cut clone 5, (Places of inserts are 
shown by vertical arrows) Asterisks: Place of insert
10 11 12 13 14
Figure 3.7: Restriction enzyme digestion of AF6-pACT construct 
Lane 1: Uncut pACT2, Lane 2: 1 Kb Ladder, Lane 3: Cut clone 1, Lane 4: Cut clone 
2, Lane 5: Cut clone 3, Lane 6: Cut clone 4, Lane 7: Cut clone 5, Lane 8: Cut clone 6, 
Lane 9: Cut clone 7, Lane 10: Cut clone 8, Lane 11: Cut clone 9, Lane 12: Cut clone 
10, Lane 13: Cut clone 11, Lane 14: Cut clone 12 (Places of inserts are shown by 
vertical arrows) Asterisks: Place of insert
61
Two of the five CASK clones (clones 3 and 5) contained inserts exactly the same 
size with the PCR product of CASK-PDZ (329 base pairs). Two of the twelve AF-6 
clones (clones 5 and 11) contained inserts exactly the same size with the PCR product of 
AF-6-PDZ (367 base pairs). These clones were further confirmed by expression studies.
The positive clones were transformed to the yeast strains and total protein was 
extracted fi'om the transformed yeast strains as explained in the materials and methods 
section. Expression of pACT2 based constructs (Csk-pACT clones and Af6-pACT 
clones) were checked in yeast (strain Y187) by SDS-PAGE followed by western blotting 
using monoclonal antibody against the Hemagglutinin (BLA). HA tag is present upstream 
of multiple cloning site of pACT2 cloning vector. The size of the GAL4 AD is 18.9 kDa 
and expected size of the GAL4 AD-CASK PDZ domain fusion protein is 29.7 kDa. 
Expected size of the GAL4 AD-AF-6 PDZ domain fusion protein is 30.6 kDa. Result is 
presented in the following figure (Figure 3.8):
Only a single construct Clone 5 of Csk-pACT expressed expected size of protein 
(p, kDa). DNA sequencing analysis was not performed for any of these constructs.
62
29.5 kDa
23.5 kDa
Figure 3.8: Expression of constructs cloned in pACT2 vector
Lane 1: Untransformed, Lane 2: Molecular Weight marker. Lane 3: pACT2 
transformed. Lane 4: Clone 3 of Csk-pACT transformed. Lane 5: Clone 5 ofCsk-pACT 
transformed. Lane 6: Clone 5 of Af6-pACT transformed. Lane 7: Clone 11 of Af6- 
pACT transformed. Lane 8 : : pACT2 transformed (places of fusion proteins are shown 
by arrows, fusion protein is shown by arrow head)
3.3- Yeast two-hybrid assay
Positive clones were transformed in yeast strains (Y187 and Y190) and colony 
lift filter assay and liquid culture assay were performed to detect protein-protein 
interaction between Syndecan-1 cytoplasmic domain and CASK PDZ domain or AF-6 
PDZ domain.
All negative and positive controls of the assay were performed to check the 
specificity of the interactions reported. Plasmids and strains were checked by control 
transformations and control yeast two hybrid assays. p-G al assay was performed using 
these transformants to determine there was no spontaneous Lac Z activity o f the vectors 
(Table 3.1).
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Each transformant is tested for its Lac Z phenotype by colony lift filter assay. White: No 
P-galactosidase expression. Blue: positive b-galactosidase expression.
T able 3 .1 : Lac Z phenotype of the transformant yeast
Transform ants / Lac Z phenotype Lac Z phenotype
Pas2-1 white
PaCT2 white
pVA3-l white
p T D l-l white
pLAM 5-l white
pC Ll blue
Sy 1-PAS white
Csk-pACT white
Af6-pACT white
Untransform ant white
Cotransformations of control vectors were performed. Colony lift filter assay is 
applied to test if the assay is working properly or not (Table 3.2).
()-l
Yeast strains Y187 and Y190 are used in this experiment. -L : leucine minus, tryptophan 
and histidine plus medium, -W: tryptophan minus, leucine and histidine plus medium, 
-H: Histidine minus, leucine and tryptophan plus medium.
Table 3.2: Control transformations for yeast-two hybrid assay
Plasmidl Plasmid 2 Selection medium Lac Z phenotype Phenotype
- pCLl -L blue
•  ·  ' ·
pAS2-l - -W white
- pACT2 -L white
pAS2-l pACT2 -L, -W white
pVA3-l - -W white
pVA3-l pACT2 -L,-W white
- pTDl-1 -L white
pAS2-l pTDl-1 -L,-W white -
pVA3-l pTDl-1 -L,-W blue ^  H  #  O
pLAM5-l - -W white
■ ·>■ ■ ·■·· '■ .. .  . ’ ../i
pLAM5-l pTDl-1 -L,-W white
CASK PDZ domain and AF-6 PDZ domain interactions with Syndecan-1 
cytoplasmic domain were determined by yeast-two hybrid assay using colony lift filter 
assay (Table 3.3).
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Table 3.3: Results of Yeast two-hybrid assay
Transformants and their Lac Z phenotype were shown. Blue coloring indicates that two 
fusion proteins, expressed by the plasmid are interacting .
Plasmid 1 Plasmid 2 Selective medium Lac Z phenotype
Syl-Pas Csk-pACT -L,-W blue
Syl-pAS Af6-pACT -L,-W white
Syl-pAS - -W white
- Csk-pACT -L white
- Af6-pACT -L white
Syl-pAS pACT2 -L, -W white
pAS2-l Csk-pACT -L, -W white
pAS2-l Af6-pACT -L,-W white
Syl-pAS pTDl-1 -L, -W blue
pLAM5-l Csk-pACT -L, -W white
pLAM5-l Af6-pACT -L,-W white
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Syndecan-1 cytoplasmic domain and CASK PDZ domain interaction is 
demonstrated in the following figure (Figure 3.9).
\
Figure 3.9: Syndecan-1 cytoplasmic domain and CASK PDZ domain interaction
Colony lift filter assay is applied to Syl-pAS and Csk-pACT cotransformed yeast. The 
small blue dots represent the expression of p-galactosidase gene indicating a protein- 
protein interaction among the fusion proteins, Sy 1 -BD and Csk-AD.
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Syndecan-l-CASK interaction was further confirmed by comparing the results of 
yeast-two hybrid assay of different transformants (Figure 3.10).
Figure 3.10: Comparison of p-galactosidase expressions in different transform ants
1: pTDl-1 and pVA3-l transformed yeast, 2: pTDl-1 and Syl-pAS transformed yeast, 
3: Syl-pAS and Csk-pACT transformed yeast, 4: Csk-pACT and pLAM5-l transformed 
yeast. Blue coloring indicates the p-galactosidase expression hence protein-protein 
interaction among fusion proteins.
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Syndecan-1 cytoplasmic domain and CASK PDZ domain interaction was 
confirmed by liquid culture assay. ONPG was used as a substrate of p-galactosidase in 
the assay. The result is presented in the following figure (Figure 3.11).
(0
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Figure 3.11: Liquid culture assay using ONPG as a substrate
1: Syl-pAS and Csk-pACT transformed yeast, 2: Syl-pAS and pTDl-1 transformed 
yeast, 3: Syl-pAS and pACT2 transformed yeast, 4: Csk-pACT and pLAM5-l 
transformed yeast, 5: Csk-pACT and pAS2-l transformed yeast, 6: Syl-pAS 
transformed yeast, 7: Csk-pACT transformed yeast. Higher P-galactosidase units mean
stronger interaction.
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4 -DISCUSSION
In this study we aimed to show a direct interaction between Syndecan-1 
cytoplasmic domain with PDZ domains o f CASK and AF-6 proteins. In previous studies 
it was reported that CASK interacts with Syndecan-2 c5doplasmic domain. This 
interaction is through PDZ domain of CASK and C2 region of Syndecan-2 cytoplasmic 
domain. C2 region o f all Syndecans are 100% identical in all family members (EFYA). 
So it is expected that a similar interaction is possible with other Syndecan family 
members. CASK PDZ domain belongs to the Type II PDZ domains which have a 
binding consensus of (Glu/Ile)-Phe-(Phe/Tyr)-(Val/Ala). This sequence match perfectly 
with the last four amino acid sequence o f all Syndecans so it is logical to think that a 
similar interaction can be seen among CASK and other Syndecans.
AF-6 is another important PDZ containing protein, which localizes to cell to cell 
junctional sites. It interacts with receptor tyrosine kinases like epinephrine receptor 
EphB3 through its PDZ domain. It also contains a Ras binding domain through which 
binds to GTP activated Ras protein and modulates its signal transduction activities. AF-6 
PDZ domain also belongs to Type II PDZ domains.
Syndecan-1 was chosen since it is known to have important regulatory functions 
in developmental processes. It probably regulates cell proliferation, cell motility, cell 
differentiation, and cell &te by modulating signaling events and cell to cell and cell to 
matrix adhesions. It is recently reported to be an important modulator of tumorigenicity 
induced by Wnt signaling pathway in mammary cancer.
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To identify Syndecan-1 cytoplasmic domain interactions with PDZ domains of 
CASK and AF-6, we used yeast to hybrid assay. This system is a recently established 
protein -protein interaction assay, which is reported to be a powerful tool to identify 
novel protein interactions. We first cloned Syndecan-1 cytoplasmic domain into yeast 
expression vector pAS2-l that it is expressed as a fusion protein with GAL4 DNA 
binding domain. CASK PDZ domain and AF-6 PDZ domain were cloned in yeast 
expression vector pACT2 as fusion proteins with GAL4 transactivating domain.
Constructs were checked by restriction enzyme digestion and it is confirmed that 
they all contain inserts of expected sizes. Seven syndecan-1 cytoplasmic domain 
containing clones, two CASK PDZ domain containing clones, and two AF-6 PDZ 
containing clones were obtained.
The reliability of the constructs were further confirmed by DNA sequencing 
analysis. But only the sequence of Syndecan-1 clones was obtained. Sequence of these 
constructs turned out to be perfect indicating the success of the cloning steps. The 
expression of fusion proteins in yeast were also checked by total protein extraction 
followed by a western-blotting. It was shown that three Syndecan-1 clones out of seven 
were expressing Syndecan-1 Cytoplasmic domain, GAL4 DB domain fusion protein. 
Only a single CASK clone were expressing PDZ domain, GAL4 AD fusion protein. 
Other clones were not expressing proteins of expected sizes.
Colony lift filter assay using X-Gal as substrate indicated that CASK PDZ 
interact with Syndecan-1 Cytoplasmic domain when expressed in yeast. A weak positive 
signal can be seen in all experiments. Interaction was not as strong as positive controls 
(p53 vs. SV40 LT Antigen) but this result is satisfactory enough for concluding that 
CASK protein binds to Syndecan-1 cytoplasmic domain.
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AF-6 clones were not expressing a fusion protein at expected size. Sequencing 
data o f these clones are also not available at the moment. The cause of expression profile 
of AF-6 clones can be clarified after sequencing results. In all occasions yeast two- 
hybrid assays gave no positive signal for AF-6 and Syndecan-1, probably because AF-6 
was not expressed in yeast. According to our hypothesis AF-6 is also interacting with 
cytoplasmic domain of Syndecan-1. The cloning of AF-6 will be performed again in 
order to obtain AF-6 PDZ, GAL4 AD fusion protein expressing clones. The yeast two- 
hybrid assays will be repeated with these clones and possible Syndecan-1 AF-6 
interaction will be identified.
Liquid culture assay using ONPG as substrate was also performed to confirm the 
results obtained fi'om the colony lift assay. A detectable interaction is also observed in 
ONPG assay. The strength of interaction is determined using spectroscopic 
measurements. CASK-Syndecan-1 interaction is quantitated by comparison of 
P-galactosidase units of this interaction with the one used for positive control. It turned 
out that CASK-Syndecan-1 interaction is one thousand fold weaker than the p53-SV40 
LTA interaction. But yet this result is significant enough for us to conclude that there is 
a physical interaction between CASK and Syndecan-1.
Our results indicated that Syndecan-1 can bind to CASK protein via its PDZ 
domain. This result is quite reasonable since a similar interaction is reported previously 
for Syndecan-2. The interaction domain of Syndecan-2 is identical to that of Syndecan-1 
(EFYA). Syndecan-1 being an important integral membrane protein is known to be 
involved in signaling events. One example of such signaling processes is Wnt signaling 
pathway (Alexander C. M. et al. 2000). Dsh protein is an immediate target for activated
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frizzled receptors. Dsh protein also contains Type II PDZ domain and it is highly 
possible that Syndecan-1 involvement in the pathway is through this PDZ protein.
CASK-Syndecan-1 interaction may be an important element of another signaling 
pathway, since CASK is known to translocate into nucleus and activate the 
transcriptional activities of some well known transcription fectors (Tbr-1). That is why 
we hypothesize that Syndecan-1 CASK interaction have important cellular function in 
vivo.
In our studies we also identified that Syndecan-1 cytoplasmic domain bind to 
SV40 LTA. This interaction was observed both in colony lift filter assay and ONPG 
assay. The strength of interaction was two fold higher than Syndecan-1-CASK 
interaction.
Syndecan-1 SV40 LTA interaction was the unexpected result o f our studies, but 
it is quite logical to think an interaction between an oncogenic antigen which transforms 
the infected cells, and an important integral membrane protein. Similar effects can be 
seen upon transfection of other oncogenic viral proteins. Increased tyrosine 
phosphorylation is reported for some insulin receptors caused by SV40 LTA transfection 
(Wang 1999). This is an example for the modification of cellular proteins by viral 
antigens. Most of these effects are indications of direct physical interactions of viral 
proteins and integral membrane proteins.
In another study it is shown that expression of Syndecan-1 increases in SV40 
LTA and adenoviral Eal transfected 293 T cell lines but not in untransfected cells 
(Numa et al. 1995). Regulation of Syndecan-1 may be an important aspect of virus 
mediated alteration of cell proliferation and cell motility. Probably by such means 
viruses cause the transformation of normal cells easily.
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4.1- Future Perspectives
We hypothesized that PDZ domains of CASK and AF-6 interact physically with 
cytoplasmic domain of Syndecan-1. We showed CASK Syndecan-1 interaction 
successfully but we could not show any interaction with AF-6 PDZ domain. This may be 
due to an error during the preparation of the constructs since we do not have the 
sequence o f the AF-6 clones, this part o f the project remains to be determined. The assay 
will be repeated with other AF-6 constructs of which their sequences and expression 
profiles are confirmed like the Syndecan-1 clones.
The protein-protein interaction may be confirmed by in vitro studies. AF-6, 
CASK, and Syndecan-1 cytoplasmic domain may be cloned in bacterial or mammalian 
expression vectors and immunoprécipitation experiments may be conducted. Purification 
columns may also be used to identify direct physical interactions. Interaction may be 
further tested in mammalian cells, in vivo. So co-localization of CASK or AF-6 with 
Syndecan-1 will be another evidence of interaction among these proteins.
Based on our hypothesis Dsh protein which also contains a Type II PDZ domain, 
may be another target protein. Protein-protein interaction of Syndecan-1 with Dsh may 
be identified by a similar approach.
Since interest subject of this study is just to identify novel protein interactions of 
Syndecan-1 core protein, screening of a cDNA library with yeast two-hybrid technique 
may be a useful tool to identify more of such interactions. Protein-protein interactions of 
Cl and V domain of Syndecan-1 protein may be identified by such techniques. Other 
important interactions may identify important signaling events that Syndecan-1 regulate 
or at least modulate.
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